Warren's bill would require that whenever drug companies enter into a settlement with the government over alleged wrongdoing, they must pay a portion of their annual profits over five years to support research at the NIH and the FDA.
The Supreme Court (SCOTUS) decision that a federals appeals court wrongly overturned Teva...
The U.S. Supreme Court on Tuesday sided with Teva Pharmaceutical in the company's high-profile...
Many healthcare and life science companies are ill-prepared for federal "whistleblower" lawsuits...
A California dietary supplement manufacturer was ordered by a federal court to stop selling its products until the company comes into compliance with the U.S. Food and Drug Administration’s dietary supplement manufacturing regulations and other requirements listed in the consent decree.
As biologic drugs like Humira and Enbrel become a larger and larger part of the pharmaceutical market, a new report from attorneys at Goodwin Procter says the introduction of lower-cost generic versions called “biosimilars” may be close at hand.
Hemispherx Biopharma announced that after prevailing in a federal lawsuit brought against the company by Cato Capital, the United States District Court for the District of Delaware has ordered Cato to pay Hemispherx attorney’s fees and costs in the amount of $770,852.76.
Sunovion Pharmaceuticals has filed patent infringement lawsuits against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications for generic copies of Latuda®.
Authorities have seized over $18M from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide. Attorney Carmen Ortiz said the funds were seized from 13 different financial institutions as a result of seizure warrants unsealed Tuesday.
A federal appeals court has left intact a judge's order for drug manufacturer Actavis PLC to keep distributing its widely used Alzheimer's medication.
The Safeway supermarket chain has been ordered to pay nearly $10M for illegally dumping batteries, electronics and pharmaceuticals in California landfills. Alameda County District Attorney Nancy O'Malley says the practice occurred at more than 500 Safeway, Vons, Pavilions and Pak 'n Save stores and distribution sites throughout California for more than seven years.
A new law expanding the Illinois medical marijuana program to children is opening a market for an unproven strain of cannabis called Charlotte's Web and a dark green, weed-fragrant oil made from it. Some parents of children with epilepsy say the oil eases their children's seizures.
The maker of the Alzheimer's drug Namenda announced it would stop selling the drug and was moving patients to a newer version called Namenda XR. But New York's attorney general filed a lawsuit, saying the practice blocked competition and was illegal.
Attorney General-elect Maura Healey says she would consider taking legal action against pharmaceutical companies to help rein in prescription drug abuse that can lead to heroin addiction.
Repros Therapeutics Inc. has announced a federal judge in Texas has issued a definitive ruling finding correct inventorship for two Repros Therapeutics Androxal(R) patents, thus confirming that Repros Therapeutics is the sole and rightful owner of the patents, U.S. Patent No. 7,759,360 (the "'360 patent") and U.S. Patent No. 7,737,185 (the "'185 patent").
The FDA is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses. The FDA warned consumers to avoid pure powdered caffeine this summer after the death of an Ohio teen. Some major retailers have stopped selling it in bulk, but the substance is still widely available on the Internet and in some stores.
A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.
A federal judge on Friday ordered home confinement and GPS monitoring for two former officials with a now-defunct Massachusetts compounding pharmacy at the center of a 2012 fungal meningitis outbreak that killed 64 people and sickened more than 750 others across the country.
Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.
A federal judge dismissed a lawsuit by 1,300 former players against the NFL, writing that the collective bargaining agreement between the league and the union was the appropriate forum to resolve claims that teams damaged the players' by routinely dispensing painkillers.
Fourteen owners or employees of a Massachusetts pharmacy were charged Wednesday in connection with a 2012 meningitis outbreak that killed 64 people nationwide and was traced to tainted drug injections.
U.S. District Judge Robert Sweet told Dublin-based Actavis PLC to continue making the drug Namenda available for 30 days after generic alternatives become available on July 11 "in order to allow for an orderly transition."
Actavis confirmed that it is filing an emergency appeal to the U.S. Court of Appeals for the Second Circuit seeking to immediately overturn a lower court ruling requiring the Company to continue distribution of NAMENDA (memantine HCl) immediate-release tablets.
The justices left in place a lower court ruling that blocked rules that regulate where and how women can take drugs that induce abortion. The rules also would prohibit the use of the abortion medications after the seventh week of pregnancy instead of the ninth.
New York's attorney general says a drug manufacturer has been ordered to halt plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.
District Judge Darlene Byrne rejected arguments from the Texas Department of Criminal Justice. The agency argued that the name of the company should be kept secret for public security reasons.
A prosecutor says he expects lawsuits following the passage of an updated lethal injection law that will make it impossible to carry out the Feb. 11 execution of a condemned child killer as planned.
Philadelphia's Transportation Authority has filed a lawsuit against Gilead Sciences over the pricing of its hepatitis C drug. Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill.
At issue was a requirement that would have told drugmakers they couldn't restrict distribution of drugs that could be used in executions. Opponents of the requirement expected the European Union would quickly ban the export of the anesthetic propofol to the U.S. if Ohio's bill became law.
- Page 1